Driehaus Small Cap Growth Investor holds a quantitatively derived Gold Morningstar Medalist Rating. The rating reflects that it has scored particularly well on factors Morningstar research associates with future outperformance relative to category peers.
Driehaus Small Cap Growth Fund Investor Class DVSMX
- NAV / 1-Day Return $27.09 / −1.53 %
- Fund Size $1.5B
- Adjusted Expense Ratio 0.930%
- Net Expense Ratio 0.910%
- Fee Level: Distribution Below Average
- Share Class Type No Load
- Morningstar Category Small Growth
- Equity Style Box (Funds) Small Growth
- Minimum Initial Investment $10,000
- Investment Status Limited
- TTM Yield 0.20%
- Turnover Ratio 152%
Morningstar’s Analysis DVSMX
Will DVSMX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 17.0
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Guardant Health Inc | 2.33 | 37M | Healthcare |
Praxis Precision Medicines Inc Ordinary Shares | 2.02 | 32M | Healthcare |
Spyre Therapeutics Inc | 1.89 | 30M | Healthcare |
JFrog Ltd Ordinary Shares | 1.67 | 27M | Technology |
Northern Institutional US Govt Sel | 1.66 | 26M | Cash and Equivalents |
Definium Therapeutics Inc Ordinary Shares | 1.62 | 26M | Healthcare |
Twist Bioscience Corp | 1.56 | 25M | Healthcare |
Xenon Pharmaceuticals Inc | 1.54 | 24M | Healthcare |
Zeta Global Holdings Corp Class A | 1.50 | 24M | Technology |
Edgewise Therapeutics Inc | 1.49 | 24M | Healthcare |